Pfizer Inc
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Nov 3, 2026Score 11/3056% above fair value
$30.52+0.57 (+1.90%)
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer All Other Specialty Care — U.S. reported YoY by Quarter
All Other Specialty Care — U.S. reported YoY (%) (%)
Pfizer All Other Specialty Care — U.S. reported YoY: 33.0% in Q2 2026, up 64.0 pts from a year earlier.
Latest, Q2 2026
33.0%
Period ended Jun 28, 2026
Change on a year earlier
+64.0 pts
-31.0% in Q2 2025
History
16 quarters
Since Q3 2022
Sources
16
Documents cited below
Where the Q2 2026 figure comes from
“|| All other Specialty Care | 566 | 453 | 25% | 24% | 302 | 228 | 33% | 264 | 225 | 17% | 14%”
Source: Form 8-K (Earnings / Guidance Release) (pfe-6282026xex99.htm, filed 2026-08-04) ↗
Reported in Form 8-K Revenue Tables.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Pfizer All Other Specialty Care — U.S. reported YoY (%), quarterly Q3 2022–Q2 2026 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/other-sc-yoy-us
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.